Diagnostyka revenue and financials
zł 160.60Change from previous close: +0.94%Absolute change: +zł 1.50
In the fiscal year ended December 2025, Diagnostyka reported revenue of zł 2.41B (+23.60% year over year). Net income was zł 251.6M, a net margin of 10.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +23.60%
- 2025 vs 2024
- Net income growth
- +12.66%
- 2025 vs 2024
- Net margin
- 10.4%
- 2024: 11.5%
Financial data
Amounts in millions of PLN; per-share values in PLN; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 2,410 | 1,950 | 1,588 | 1,436 | — |
| Cost of revenue | 505 | 420 | 555 | 500 | — |
| Gross profit | 1,905 | 1,530 | 1,033 | 936 | — |
| Operating income | 384 | 337 | 233 | 252 | — |
| EBIT | 386 | 349 | 228 | 255 | — |
| EBITDA | 588 | 510 | 375 | 381 | — |
| Interest expense | 68.9 | 57.4 | 54.2 | 32.8 | — |
| Pre-tax income | 317 | 291 | 174 | 222 | — |
| Income tax | 55.0 | 59.2 | 43.6 | 50.2 | — |
| Net income | 252 | 223 | 123 | 167 | — |
| Net income to common shareholders | 252 | 223 | 123 | 167 | — |
| Basic EPS | 7.45 | 6.62 | 3.66 | 4.96 | — |
| Diluted EPS | 7.45 | 6.62 | 3.66 | 4.96 | — |
| Average shares (basic) | 33.8 | 33.8 | 33.8 | 33.8 | — |
| Average shares (diluted) | 33.8 | 33.8 | 33.8 | 33.8 | — |